Skye Bioscience, Inc
Skye Bioscience, Inc. is a biotechnology firm based in San Diego, California, focused on developing innovative therapies for obesity and other metabolic diseases. The company is advancing first-in-class molecules that target G-protein coupled receptors, aiming to enhance health outcomes for patients with significant unmet needs.
With a commitment to applying best practices throughout drug design and development, Skye Bioscience emphasizes the development of its lead candidate, Nimacimab, a peripheral CB1-inhibiting antibody. The company aims to deliver sustainable weight loss solutions, improve drug tolerability, and ultimately broaden therapeutic options for the diverse obesity market.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

